A Pilot Study of Tumor-Derived Exosomes as Diagnostic and Prognostic Markers in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
Status: WITHDRAWN
Study type: OBSERVATIONAL
Conditions: Breast Neoplasms
Sponsor: Leo W. Jenkins Cancer Center